Home Human Medicines Homeopathy

print this page

register

The MEB and homeopathic medicinal products
In 1992, it was agreed at European level that homeopathic medicinal products must be authorised in all European member states. This was incorporated into Dutch medicines legislation in 1995. The main reason for assessing this type of medicinal product is to provide the user with the assurance that the product is of high quality and guaranteed safety. In addition, the information on the homeopathic medicinal product for the consumer and the prescriber is assessed, to ensure that the product can be used safely.

Homeopathic products are used extensively and it is to be expected that this will remain so in the future. In the Netherlands, the Medicines Evaluation Board is responsible for the authorisation process of these products. The MEB also accepted the task of assessing homeopathic products because it views this activity as part of its responsibility for all medicinal products on the Dutch market. The MEB undertook this responsibility following extensive discussions within the MEB.

Bookmark and Share

Back